Literature DB >> 24485387

Oxidation and nitration in dopaminergic areas of the prefrontal cortex from patients with bipolar disorder and schizophrenia.

Helena Kyunghee Kim1, Ana Cristina Andreazza2, Pok Yik Yeung1, Cameron Isaacs-Trepanier3, L Trevor Young2.   

Abstract

BACKGROUND: Increased oxidative stress is strongly implicated in bipolar disorder (BD), where protein oxidation, lipid peroxidation and oxidative damage to DNA have been consistently reported. High levels of dopamine (DA) in mania are also well-recognized in patients with BD, and DA produces reactive oxygen species and electron-deficient quinones that can oxidize proteins when it is metabolized.
METHODS: Using immunohistochemistry and acceptor photobleaching Förster resonance energy transfer (FRET), we examined oxidation and nitration of areas immunoreactive for the DA transporter (DAT) and tyrosine hydroxylase (TH) in the postmortem prefrontal cortex from patients with BD, schizophrenia and major depression as well as nonpsychiatric controls.
RESULTS: We found increased oxidation of DAT-immunoreactive regions in patients with BD (F3,48 = 6.76, p = 0.001; Dunnett post hoc test p = 0.001) and decreased nitration of TH-immunoreactive regions in both patients with BD (F3,45 = 3.10, p = 0.036; Dunnett post hoc test p = 0.011) and schizophrenia (p = 0.027). On the other hand, we found increased global levels of oxidation in patients with BD (F3,44 = 6.74, p = 0.001; Dunnett post hoc test p = 0.001) and schizophrenia (p = 0.020), although nitration levels did not differ between the groups (F3,46 = 1.75; p = 0.17). LIMITATIONS: Limitations of this study include the use of postmortem brain sections, which may have been affected by factors such as postmortem interval and antemortem agonal states, although demographic factors and postmortem interval were accounted for in our statistical analysis.
CONCLUSION: These findings suggest alterations in levels of protein oxidation and nitration in DA-rich regions of the prefrontal cortex in patients with BD and schizophrenia, but more markedly in those with BD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24485387      PMCID: PMC4074239          DOI: 10.1503/jpn.130155

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  58 in total

1.  Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine.

Authors:  Samira S Valvassori; Gislaine T Rezin; Camila L Ferreira; Morgana Moretti; Cinara L Gonçalves; Mariana R Cardoso; Emílio L Streck; Flávio Kapczinski; João Quevedo
Journal:  J Psychiatr Res       Date:  2010-03-23       Impact factor: 4.791

2.  The increasing medical burden in bipolar disorder.

Authors:  David J Kupfer
Journal:  JAMA       Date:  2005-05-25       Impact factor: 56.272

3.  Immunohistochemical staining of post-mortem adult human brain sections.

Authors:  Henry J Waldvogel; Maurice A Curtis; Kristin Baer; Mark I Rees; Richard L M Faull
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

4.  A close association of torsinA and alpha-synuclein in Lewy bodies: a fluorescence resonance energy transfer study.

Authors:  N Sharma; J Hewett; L J Ozelius; V Ramesh; P J McLean; X O Breakefield; B T Hyman
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

5.  Prefrontal cortex in humans and apes: a comparative study of area 10.

Authors:  K Semendeferi; E Armstrong; A Schleicher; K Zilles; G W Van Hoesen
Journal:  Am J Phys Anthropol       Date:  2001-03       Impact factor: 2.868

6.  Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder.

Authors:  Ana C Andreazza; Li Shao; Jun-Feng Wang; L Trevor Young
Journal:  Arch Gen Psychiatry       Date:  2010-04

7.  Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania.

Authors:  Benicio N Frey; Samira S Valvassori; Gislaine Z Réus; Márcio R Martins; Fabrícia C Petronilho; Katrine Bardini; Felipe Dal-Pizzol; Flávio Kapczinski; João Quevedo
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

8.  Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.

Authors:  T G Hastings; D A Lewis; M J Zigmond
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

Review 9.  The neurobiology of the switch process in bipolar disorder: a review.

Authors:  Giacomo Salvadore; Jorge A Quiroz; Rodrigo Machado-Vieira; Ioline D Henter; Husseini K Manji; Carlos A Zarate
Journal:  J Clin Psychiatry       Date:  2010-05-04       Impact factor: 4.384

Review 10.  Oxidative stress markers in bipolar disorder: a meta-analysis.

Authors:  Ana C Andreazza; Marcia Kauer-Sant'anna; Benicio N Frey; David J Bond; Flavio Kapczinski; L Trevor Young; Lakshmi N Yatham
Journal:  J Affect Disord       Date:  2008-06-09       Impact factor: 4.839

View more
  22 in total

Review 1.  Heterogeneity of dopamine release sites in health and degeneration.

Authors:  Joseph J Lebowitz; Habibeh Khoshbouei
Journal:  Neurobiol Dis       Date:  2019-11-05       Impact factor: 5.996

Review 2.  Vitamin D deficiency accelerates ageing and age-related diseases: a novel hypothesis.

Authors:  Michael J Berridge
Journal:  J Physiol       Date:  2017-10-31       Impact factor: 5.182

3.  Mitochondrial dysfunction and lipid peroxidation in rat frontal cortex by chronic NMDA administration can be partially prevented by lithium treatment.

Authors:  Helena K Kim; Cameron Isaacs-Trepanier; Nika Elmi; Stanley I Rapoport; Ana C Andreazza
Journal:  J Psychiatr Res       Date:  2016-02-06       Impact factor: 4.791

4.  Resveratrol protects the brain against oxidative damage in a dopaminergic animal model of mania.

Authors:  Samira Menegas; Camila L Ferreira; José Henrique Cararo; Fernanda F Gava; Gustavo C Dal-Pont; Maria L Gomes; Jotele F Agostini; Patrícia Fernanda Schuck; Giselli Scaini; Monica L Andersen; João Quevedo; Samira S Valvassori
Journal:  Metab Brain Dis       Date:  2019-03-27       Impact factor: 3.584

Review 5.  Neurocognitive, Neuroprotective, and Cardiometabolic Effects of Raloxifene: Potential for Improving Therapeutic Outcomes in Schizophrenia.

Authors:  Mohammad M Khan
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

Review 6.  Current state of biomarkers in bipolar disorder.

Authors:  Gustavo Scola; Ana Cristina Andreazza
Journal:  Curr Psychiatry Rep       Date:  2014-12       Impact factor: 5.285

7.  L-Tyrosine availability affects basal and stimulated catecholamine indices in prefrontal cortex and striatum of the rat.

Authors:  Zachary D Brodnik; Manda Double; Rodrigo A España; George E Jaskiw
Journal:  Neuropharmacology       Date:  2017-05-29       Impact factor: 5.250

Review 8.  Lipid peroxidation in psychiatric illness: overview of clinical evidence.

Authors:  Yash B Joshi; Domenico Praticò
Journal:  Oxid Med Cell Longev       Date:  2014-04-27       Impact factor: 6.543

9.  Could selenium administration alleviate the disturbances of blood parameters caused by lithium administration in rats?

Authors:  Małgorzata Kiełczykowska; Joanna Kocot; Jacek Kurzepa; Anna Lewandowska; Renata Żelazowska; Irena Musik
Journal:  Biol Trace Elem Res       Date:  2014-03-28       Impact factor: 3.738

Review 10.  Redox Modulations, Antioxidants, and Neuropsychiatric Disorders.

Authors:  Erik A Fraunberger; Gustavo Scola; Victoria L M Laliberté; Angela Duong; Ana C Andreazza
Journal:  Oxid Med Cell Longev       Date:  2015-11-10       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.